Longevity Technology(@LongevityTech):AbbVie’s JUVMO (tavapadon) targets dopamine differently from older drugs and is expected in US pharmacies this month, the company says. https://t.co/GcvpgSJ3OY #longevity #AbbVie #JUVMO #tavapadon #dopamine

Longevity Technology

@LongevityTech

Daily news and insights on research, investments and technologies that extend life and improve the quality of that extended life. #Longevity#

加入 December 2018

2.3K 正在关注 19K 粉丝

Longevity Technology@LongevityTech

2026.10.07 13:14

AbbVie’s JUVMO (tavapadon) targets dopamine differently from older drugs and is expected in US pharmacies this month, the company says. #longevity# #AbbVie# #JUVMO# #tavapadon# #dopamine#

显示更多

转发到社区

热门用户

140.1K 粉丝

317.8K 粉丝

40.1K 粉丝

2M 粉丝

260.1K 粉丝

101.7K 粉丝

182.9K 粉丝

3.4M 粉丝

579K 粉丝

4.3M 粉丝

549.7K 粉丝

28.3K 粉丝

196.3K 粉丝

26.4M 粉丝

111K 粉丝